ITRMF (Iterum Therapeutics) Total Assets: $32.50 Mil (As of Sep. 2025)


What is Iterum Therapeutics Total Assets?

Iterum Therapeutics ITRMF +18.86% Total Assets is $32.50 Mil as of Sep. 2025. The stock has 4 warning signs investors should review.

Iterum Therapeutics's Total Assets for the quarter that ended in Sep. 2025 was $32.50 Mil.

During the past 12 months, Iterum Therapeutics's average Total Assets Growth Rate was 1412.00% per year. During the past 3 years, the average Total Assets Growth Rate was 26.40% per year. During the past 5 years, the average Total Assets Growth Rate was -16.70% per year.

During the past 9 years, Iterum Therapeutics's highest 3-Year average Total Assets Growth Rate was 115.00%. The lowest was -47.30%. And the median was 8.85%.

Total Assets is connected with ROA %. Iterum Therapeutics's annualized ROA % for the quarter that ended in Sep. 2025 was -107.99%. Total Assets is also linked to Revenue through Asset Turnover. Iterum Therapeutics's Asset Turnover for the quarter that ended in Sep. 2025 was 0.01.

Iterum Therapeutics  (OTCPK:ITRMF) Total Assets Explanation

Total Assets is connected with ROA %.

Iterum Therapeutics's annualized ROA % for the quarter that ended in Sep. 2025 is

ROA %=Net Income (Q: Sep. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Sep. 2025 ))/ count )
=-35.916/( (34.014+32.503)/ 2 )
=-35.916/33.2585
=-107.99 %

Note: The Net Income data used here is four times the quarterly (Sep. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Iterum Therapeutics's Asset Turnover for the quarter that ended in Sep. 2025 is

Asset Turnover
=Revenue (Q: Sep. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Sep. 2025 ))/ count )
=0.39/( (34.014+32.503)/ 2 )
=0.39/33.2585
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Iterum Therapeutics Total Assets Related Terms

Iterum Therapeutics Total Assets Historical Data

* Premium members only.

The historical data trend for Iterum Therapeutics's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Iterum Therapeutics Total Assets Chart

Iterum Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Assets
Get a 7-Day Free Trial Premium Member Only 32.79 91.51 66.83 26.26 44.60

Iterum Therapeutics Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.92 44.60 32.98 34.01 32.50

Iterum Therapeutics Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Iterum Therapeutics's Total Assets for the fiscal year that ended in Dec. 2024 is calculated as

Total Assets=Total Equity (A: Dec. 2024 )+Total Liabilities (A: Dec. 2024 )
=-4.081+48.676
=44.60

Iterum Therapeutics's Total Assets for the quarter that ended in Sep. 2025 is calculated as

Total Assets=Total Equity (Q: Sep. 2025 )+Total Liabilities (Q: Sep. 2025 )
=-7.381+39.884
=32.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $32.50 Mil mean?
Iterum Therapeutics (ITRMF) has a Total Assets of $32.50 Mil as of Sep. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on Iterum Therapeutics and its competitors.
Is Iterum Therapeutics' Total Assets too high?
Iterum Therapeutics' current Total Assets is $32.50 Mil.
How does Iterum Therapeutics' Total Assets compare to ENSC and PPCB?
Iterum Therapeutics' Total Assets of $32.50 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Iterum Therapeutics and its competitors. Iterum Therapeutics's current Total Assets is $32.50 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Iterum Therapeutics stock overvalued right now?
Iterum Therapeutics (ITRMF) has a current Total Assets of $32.50 Mil. The current Total Assets is $32.50 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Iterum Therapeutics (ITRMF), the current Total Assets is $32.50 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Iterum Therapeutics Business Description

Address 3 Dublin Landings, North Wall Quay, Dublin 1, Dublin, IRL, D01 C4E0
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.